Professor Marcus Schultz
Honorary Visiting Research Fellow in Critical Care
Prof. Dr. Marcus J. Schultz completed his medical degree cum laude (with distinction) and residency in internal medicine at the University of Amsterdam and the Academic Medical Center, Amsterdam, The Netherlands. He obtained his doctorate at the same university.
Prof. Schultz is currently an intensivist and one of the Principal Investigators of the Academic Medical Center and professor of Intensive Care Medicine at University of Amsterdam. For 10 years, he was co–chair of the ‘Laboratory of Experimental Intensive Care and Anaesthesiology’ (L·E·I·C·A), a university–based laboratory specialized in translational research in the filed of mechanical ventilation. He is a founding member of the ‘PROtective VEntilation Network’ (PROVENet), a worldwide collaboration of intensivists and anaesthesiologist in ventilation research and lung protection.
Marcus Schultz has performed over 60 clinical trials, published numerous articles in medical journals and various chapters in scientific books, has received several research awards, and serves as a reviewer and editor of numerous international medical journals.
His main research interests are in the area of lung injury, pneumonia and mechanical ventilation. Marcus Schultz initiated several studies focusing on mechanical ventilation settings during general anaesthesia for surgery. Marcus Schultz initiated national and international projects aiming at implementation of intensive care unit strategies in daily critical care practice in high–income countries as well as in resource–limited ICUs in middle– and low–income countries (Pakistan, India, Bangladesh, Nepal, Sri Lanka, Maldives, Malaysia, Myanmar, Thailand, Vietnam, and Brazil).
Closed-loop oxygen control improves oxygen therapy in acute hypoxemic respiratory failure patients under high flow nasal oxygen: a randomized cross-over study (the HILOOP study).
Roca O. et al, (2022), Critical care (London, England), 26
Mechanical ventilators for low- and middle-income countries: informing a context-specific and sustainable design
Gallifant J. et al, (2022), British Journal of Anaesthesia, 128, e279 - e281
Patients with hypothermic sepsis have a unique gene expression profile compared to patients with fever and sepsis
Harmon MBA. et al, (2022), JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Going Micro in Leptospirosis Kidney Disease.
Chancharoenthana W. et al, (2022), Cells, 11
The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19.
Atmowihardjo L. et al, (2022), Trials, 23